Yu M, Honoki K, Andersen J, Paietta E, Nam D K, Yunis J J
Cancer Biology Division, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Leukemia. 1996 May;10(5):774-80.
Rearrangement of the MLL (myeloid-lymphoid or mixed-lineage leukemia) gene through a reciprocal chromosomal translocation is found in 5% of adult acute myeloid (AML) and 10% of pediatric acute lymphoid (ALL) leukemia. More than 25 different reciprocal chromosomal translocations, with an 11q23 breakpoint, fuse the MLL gene (also named ALL-1, HRX and Htrx1) to a second partner gene. These leukemias have poor prognosis and frequently have a monocytic, lymphoid or biphenotypic (myeloid and lymphoid) antigen expression in blast cells. Approximately 20-30% of patients diagnosed as having adult de novo, AML have normal chromosomes by metaphase analysis and the majority of these patients have good prognosis. With the use of reverse transcriptase-polymerase chain reaction (RT-PCR) technique and Southern blot analysis, we found that seven of 34 such patients (21%) had a tandem partial duplication of exons 2 to 6 or 2 to 8 of the MLL gene. These seven patients showed a median survival of 2.7 months, compared to a 6.8 months median survival for all other patients in the study. If confirmed on a large series of patients, our findings may help differentiate AML with normal karyotype and poor prognosis from those with normal karyotype and a more favorable prognosis.
通过相互染色体易位导致的MLL(髓系-淋巴系或混合系白血病)基因重排在5%的成人急性髓系白血病(AML)和10%的儿童急性淋巴细胞白血病(ALL)中被发现。超过25种不同的相互染色体易位,其断点位于11q23,将MLL基因(也称为ALL-1、HRX和Htrx1)与第二个伙伴基因融合。这些白血病预后较差,原始细胞中常具有单核细胞、淋巴细胞或双表型(髓系和淋巴系)抗原表达。通过中期分析,约20%-30%被诊断为成人新发AML的患者染色体正常,这些患者中的大多数预后良好。利用逆转录聚合酶链反应(RT-PCR)技术和Southern印迹分析,我们发现34例此类患者中有7例(21%)存在MLL基因外显子2至6或2至8的串联部分重复。这7例患者的中位生存期为2.7个月,而研究中所有其他患者的中位生存期为6.8个月。如果在大量患者中得到证实,我们的发现可能有助于区分核型正常但预后较差的AML与核型正常且预后较好的AML。